Ying-Hong Wang
Overview
Explore the profile of Ying-Hong Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma
Singh S, Bradford D, Chatterjee S, Li X, Aungst S, Skinner A, et al.
Clin Cancer Res
. 2025 Jan;
PMID: 39808502
On April 23, 2024, FDA granted accelerated approval to tovorafenib, a type II RAF kinase inhibitor, for the treatment of patients 6 months of age and older with relapsed or...
2.
Dharmapuri S, Ozbek U, Jethra H, Jun T, Marron T, Saeed A, et al.
World J Gastrointest Oncol
. 2023 Dec;
15(11):1900-1912.
PMID: 38077640
Background: A well-recognized class effect of immune checkpoint inhibitors (ICI) is immune-related adverse events (IrAEs) ranging from low grade toxicities to life-threatening end organ damage requiring permanent discontinuation of ICI....
3.
Li Y, Adi D, Wang Y, Wang Y, Li X, Fu Z, et al.
PeerJ
. 2023 Jun;
11:e15536.
PMID: 37361044
Objective: The human Disabled-2 (Dab2) protein is an endocytic adaptor protein, which plays an essential role in endocytosis of transmembrane cargo, including low-density lipoprotein cholesterol (LDL-C). As a candidate gene...
4.
Menzel K, Kuo Y, Chen D, Hartmann G, Wang Y, Cho C, et al.
Clin Transl Sci
. 2023 Apr;
16(6):1039-1048.
PMID: 37085998
Letermovir is approved for use in cytomegalovirus-seropositive hematopoietic stem cell transplant recipients and is investigated in other transplant settings. Nonlinear pharmacokinetics (PKs) were observed in clinical studies after intravenous and...
5.
Yang S, Zhang G, Zhang J, Li T, Zhao Z, Wang Y, et al.
J Asian Nat Prod Res
. 2022 Nov;
25(7):697-703.
PMID: 36409210
A total synthesis approach of CS-E oligosaccharides was established and a series of derivatives were synthesized. These oligosaccharides were evaluated for a glycosaminoglycan (GAG)-binding protein interaction against cytokines, midkine, and...
6.
Klein R, Layton M, Regan H, Regan C, Li Y, Filzen T, et al.
Channels (Austin)
. 2022 Oct;
16(1):230-243.
PMID: 36239534
As part of a drug discovery effort to identify potent inhibitors of NaV1.7 for the treatment of pain, we observed that inhibitors produced unexpected cardiovascular and respiratory effects in vivo....
7.
Li X, Sheng K, Wang Y, Dong Y, Jiang Z, Sun J
Open Life Sci
. 2022 Sep;
17(1):1094-1103.
PMID: 36160632
Irrigation regimes should be chosen to maximize crop yield and water use efficiency. To realize high yield and efficient water use with the appropriate furrow irrigation regime, the effects of...
8.
Cai M, Ni W, Wang Y, Wang J, Zhou H
Front Oncol
. 2022 Jun;
12:906372.
PMID: 35734592
According to authoritative surveys, the overall morbidity and mortality of malignant tumors show an upward trend, and it is predicted that this trend will not be well contained in the...
9.
Przepiorka D, Le R, Ionan A, Li R, Wang Y, Gudi R, et al.
Clin Cancer Res
. 2022 Feb;
28(12):2488-2492.
PMID: 35135839
On July 16, 2021, the FDA approved belumosudil, a kinase inhibitor, for adult and pediatric patients 12 years and older with chronic GvHD (cGvHD) after failure of at least two...
10.
Huang Y, Chen X, Wang Y, Liu Z, Tang G, Li X
Huan Jing Ke Xue
. 2021 Sep;
42(10):4602-4610.
PMID: 34581102
To reveal the characteristics of photochemical pollution in North China, adsorbing columns with 2, 4-dinitrophenylhydrazine(DNPH) were used to sample carbonyl compounds in Shijiazhuang and Xinglong between May 2018 and April...